SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20052721
Source:
http://linkedlifedata.com/resource/pubmed/id/20052721
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0034656
,
umls-concept:C0086960
,
umls-concept:C0087111
,
umls-concept:C0144576
,
umls-concept:C0205390
,
umls-concept:C0278488
,
umls-concept:C0574032
,
umls-concept:C1554217
pubmed:issue
4
pubmed:dateCreated
2010-2-9
pubmed:abstractText
This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3-hour versus 96-hour infusion schedules.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA45809
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0008-543X
pubmed:author
pubmed-author:ArbuckSusan GSG
,
pubmed-author:BroglioKristineK
,
pubmed-author:BuzdarAman UAU
,
pubmed-author:HolmesFrankie AFA
,
pubmed-author:HortobagyiGabriel NGN
,
pubmed-author:MoulderStacy LSL
,
pubmed-author:SeidmanAndrewA
,
pubmed-author:ThallPeterP
,
pubmed-author:TolcherAnthony WAW
,
pubmed-author:ValeroVicenteV
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
814-21
pubmed:meshHeading
pubmed-meshheading:20052721-Adult
,
pubmed-meshheading:20052721-Aged
,
pubmed-meshheading:20052721-Aged, 80 and over
,
pubmed-meshheading:20052721-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:20052721-Breast Neoplasms
,
pubmed-meshheading:20052721-Disease-Free Survival
,
pubmed-meshheading:20052721-Drug Administration Schedule
,
pubmed-meshheading:20052721-Drug Resistance, Neoplasm
,
pubmed-meshheading:20052721-Female
,
pubmed-meshheading:20052721-Humans
,
pubmed-meshheading:20052721-Infusions, Intravenous
,
pubmed-meshheading:20052721-Middle Aged
,
pubmed-meshheading:20052721-Neoplasm Metastasis
,
pubmed-meshheading:20052721-Paclitaxel
,
pubmed-meshheading:20052721-Survival Rate
pubmed:year
2010
pubmed:articleTitle
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.
pubmed:affiliation
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301438, Houston, TX 77030, USA. smoulder@mdanderson.org
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Research Support, N.I.H., Extramural